Clinical Trial Update: Zofin (Organicell Flow) for Patients With COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Zofin (Organicell Flow) in COVID-19 patients, reporting Phase 1 and Phase 2 completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Zofin

Snippet

Sponsor: ZEO ScientifiX, Inc. | Conditions: Corona Virus Infection, COVID-19 | Phase 1, Phase 2 | Status: COMPLETED